The 4th Annual NASH Roundtable Forum took place on November 18, 2021, with presentations and a Roundtable Member discussion focused on opportunities for collaboration bridging expertise from pharma, biotech, clinical research, and academic research. Forum moderators were Dr. Marcus Hompesch and Dr. Rohit Loomba. Presenters were Dr. Arun Sanyal, Dr. Julio Gutierrez, Dr. Morten Karsdal, and Dr. Lars Johansson. You can now view a recording of the entire Roundtable Forum or the individual presentations.
Please contact us to request access to the NASH Roundtable Forum video recordings or email us directly at nashroundtable@prosciento.com for more information.
Video Recording of Full Event Now Available:
4th Annual NASH Roundtable™ Forum
View a full video recording of the NASH Roundtable Forum
Approximately 2.5 hours
Individual Presentations Available:
Utilizing NASH PASS® Biobank for Biomarker Discovery and Translational Research
Presented by Julio Gutierrez, MD, Vice President of Clinical Research and Clinical Science, ProSciento, Inc. and Transplant Hepatologist at Scripps Health
Approximately 20 minutes
Collaborative Translational Research Opportunities Utilizing the NASH PASS® Biobank
Presented by Arun J. Sanyal, MD, Professor, Division of Gastroenterology, Hepatology and Nutrition, at Virginia Commonwealth University School of Medicine
Approximately 20 minutes
Biomarkers of Hepatic Fibrosis, Fibrogenesis, and Fibrosis Resolution
Presented by Morten Karsdal, PhD, Chief Executive Officer, Nordic Bioscience A/S
Approximately 15 minutes
Advances in Imaging Technologies for Fibrotic Diseases – A Look Forward
Presented by Lars Johansson, PhD, Chief Scientific Officer, Antaros Medical AB
Approximately 15 minutes
About the NASH Roundtable
The NASH Roundtable was established in 2018 as a platform to stimulate collaboration and build consensus towards validated biomarkers and endpoints and to support the development of effective and safe treatments. Today the Roundtable consists of distinguished physicians, researchers, and clinical development experts from three continents brought together by their common commitment to steward advances in science, clinical research, and therapeutics for fibrotic diseases.
